Copyright © 2013 Knight Sac Media. All rights reserved.http://www.siliconinvestor.com/subject.aspx?subjectid=58313VistaGen Therapeutics, Inc. is a biotechnology company applying stem cell technol¬ogy for drug rescue and cell therapy. Drug rescue combines human stem cell technology with modern medicinal chemistry to generate new chemical variants (drug rescue variants) of promising drug candidates that have been...http://www.siliconinvestor.com/images/Logo380x132.pnghttp://www.siliconinvestor.com/subject.aspx?subjectid=5831338013210MissionIRVistaGen Therapeutics, Inc. (VSTA) and the Frankenstein Revolution Some call it the Frankenstein revolution, but the fact is that it heralds what may become one of the most important developments in 21st Century medical science. It’s the use of stem cell technology to build living organisms in the laboratory, paving t...http://www.siliconinvestor.com/readmsg.aspx?msgid=289099185/22/2013 5:56:58 PMMissionIRVistaGen Therapeutics, Inc. (VSTA) Continues to Move Forward with Revolutionary Drug Testing Technology VistaGen is a biotech company focused on using stem cell technology to generate new, safer variants (drug rescue variants) of once-promising small molecule drug candidates that were developed but ultimately disconti...http://www.siliconinvestor.com/readmsg.aspx?msgid=288961655/15/2013 1:58:25 PMMissionIRVistaGen Therapeutics, Inc. (VSTA) and Duke University Report Positive Results on Production of Functional 3D Human Heart Tissue VistaGen Therapeutics, a biotech company focused on applying stem cell technology for drug rescue, predictive toxicology, and drug metabolism assays, reports that its human pluripotent stem ...http://www.siliconinvestor.com/readmsg.aspx?msgid=288800495/7/2013 11:26:04 AMMissionIRVistaGen Therapeutics, Inc. (VSTA) Positioned to Benefit from Multiple Monetization Options Stem cell technology has traditionally been associated with therapeutic regeneration, using these basic building blocks of life to generate new cells that can replace damaged cells. Potential therapeutic applications run the ga...http://www.siliconinvestor.com/readmsg.aspx?msgid=288711735/2/2013 2:30:23 PMMissionIRVistaGen Therapeutics, Inc. (VSTA) Turns a Billion Dollar Problem into a One-Of-A-Kind Opportunity The strategy of VistaGen Therapeutics, a California based stem-cell technology company, is primed to drive rapid growth because of its unique structure. VistaGen is a developer of stem-cell based bioassay early-warning s...http://www.siliconinvestor.com/readmsg.aspx?msgid=288585094/25/2013 1:43:22 PMMissionIRValue of VistaGen Therapeutics, Inc. (VSTA) is Seen in Pharmaceutical Disasters The importance of the work being done at VistaGen Therapeutics, developers of stem-cell based bioassay early-warning systems for determining possible toxicity of drug candidates, can be seen in the clinical disasters occasionally experienc...http://www.siliconinvestor.com/readmsg.aspx?msgid=288440844/18/2013 2:51:30 PMMissionIRVistaGen Therapeutics, Inc. (VSTA) Secures $36 Million to Accelerate Drug Rescue, Predictive Toxicology, and Drug Metabolism Programs VistaGen Therapeutics, a biotechnology company with stem cell technology designed to improve the predictability of the drug development cycle and lower the cost of new drug R&D, just an...http://www.siliconinvestor.com/readmsg.aspx?msgid=288256844/10/2013 9:27:51 AMMissionIRCase Summary for VistaGen Therapeutics, Inc. (VSTA) VistaGen Therapeutics is a California biotechnology company focused primarily on the use of its proprietary pluripotent stem cell technology to discover, rescue, and develop novel drug candidates for a wide range of diseases. The core of the company’s strategy is t...http://www.siliconinvestor.com/readmsg.aspx?msgid=288161854/4/2013 3:30:40 PMMissionIRVistaGen Therapeutics, Inc. (VSTA) Uses Stem Cells to Build a Better Scientific Model for Drug Development Why do pharmaceutical drugs cost so much? Because pharmaceutical companies waste so much money and time developing them. But these companies can be excused for wasting hundreds of millions of dollars and yea...http://www.siliconinvestor.com/readmsg.aspx?msgid=288021283/27/2013 12:27:43 PMMissionIRVistaGen Therapeutics, Inc. (VSTA) Secures Spot at World’s Premier Toxicology Conference to Present Latest Enhancements and Expanded Validation of LiverSafe 3D™ VistaGen Therapeutics, a biotechnology company applying stem cell technology for drug rescue, predictive toxicology, and drug metabolism assays, has been sc...http://www.siliconinvestor.com/readmsg.aspx?msgid=287746183/12/2013 2:05:30 PMMissionIRVistaGen Therapeutics, Inc. (VSTA) to Present Expanded and Improved Applications of Stem-Based Screening System for Heart Toxicity VistaGen Therapeutics, a biotechnology company applying stem cell technology for drug rescue, predictive toxicology, and drug metabolism assays, just announced it will feature key develo...http://www.siliconinvestor.com/readmsg.aspx?msgid=287722363/11/2013 1:02:07 PMQualityStocksVistaGen Therapeutics, Inc. (VSTA) to Further Advance LiverSafe 3D™ Technology via Strategic Collaboration with Celsis Today before the opening bell, VistaGen Therapeutics, a biotechnology company applying stem cell technology for drug rescue, predictive toxicology, and drug metabolism assays, announced it has entered...http://www.siliconinvestor.com/readmsg.aspx?msgid=287583733/4/2013 9:22:40 AMMissionIRVistaGen Therapeutics, Inc. (VSTA) Partnerships and Pending Agreements When it comes to the pharmaceutical world, few things are more important than current and future relationships with other companies and organizations. For emerging companies, partnerships are often critical, helping to drive research and build po...http://www.siliconinvestor.com/readmsg.aspx?msgid=287551073/1/2013 7:47:33 PMMissionIRVistaGen Therapeutics, Inc. (VSTA) and the Rising Cost of Medicines If there is one thing that seems to define modern health care, it’s costs. Today, there are options that never had to be considered in the past, but options that come at a price. High-tech healthcare costs money, but most people are also glad to hav...http://www.siliconinvestor.com/readmsg.aspx?msgid=287407472/22/2013 11:35:18 AMMissionIRVistaGen Therapeutics, Inc. (VSTA) – A Prime Example of Stem Cell Application Diversity The advent of stem cell technology is proving to be one of the most foundational developments in the history of modern medicine. Like the stem cell itself, this rapidly developing technology is showing a remarkable ability to tra...http://www.siliconinvestor.com/readmsg.aspx?msgid=287262912/14/2013 3:10:06 PMMissionIRVistaGen Therapeutics, Inc. (VSTA) Progress in the Labs Enable Advanced Tools for Drug Rescue and Potential Cell Therapies VistaGen Therapeutics, a biotechnology company applying stem cell technology for drug rescue, predictive toxicology, and drug metabolism assays, earlier today announced significant advancements ...http://www.siliconinvestor.com/readmsg.aspx?msgid=287119642/7/2013 1:05:57 PMMissionIRVistaGen Therapeutics, Inc. (VSTA) to Profit from Growing Need for Better Approach A recent article by Ryan McBride in biotech industry newsletter FierceBiotech (http://dtg.fm/i12W) highlights a major transition that needs to occur in the pharmaceutical industry. The article points to a speech by Ken Kaitin, dir...http://www.siliconinvestor.com/readmsg.aspx?msgid=286967611/30/2013 6:00:46 PMMissionIRVistaGen's presentation at Noble Financial's conference begins in one hour at 12:30pm ET. Live webcast link: dtg.fm  Shawn K. Singh, CEO of VistaGen, will discuss VistaGen's progress and unique opportunities to apply its stem cell technology platform, Human Clinical Trials in a Test Tube™, for drug rescue, predi...http://www.siliconinvestor.com/readmsg.aspx?msgid=286817561/23/2013 11:34:36 AMMissionIRVistaGen Therapeutics, Inc. (VSTA) Proclaims Completion of AV-101’s Final Phase 1 Safety Study VistaGen Therapeutics, a biotechnology company applying stem cell technology for drug rescue, predictive toxicology, and drug metabolism screening, excitedly reported today the successful completion of its final Phase 1 sa...http://www.siliconinvestor.com/readmsg.aspx?msgid=286814961/23/2013 9:40:50 AMMissionIRVistaGen Therapeutics, Inc. (VSTA) Scheduled to Present at Noble Financial Capital Markets 9th Annual Equity Conference Today before the opening bell, VistaGen Therapeutics, a biotechnology company applying stem cell technology for drug rescue, predictive toxicology, and drug metabolism screening, told investors tha...http://www.siliconinvestor.com/readmsg.aspx?msgid=286792151/22/2013 9:43:59 AMMissionIRVistaGen Therapeutics, Inc. (VSTA) Taps Key Research Institutions to Achieve Strategic Objectives California-based VistaGen Therapeutics, a biotechnology company applying proprietary human pluripotent stem cell technology for drug rescue, predictive toxicology, and drug metabolism screening, has been highly effectiv...http://www.siliconinvestor.com/readmsg.aspx?msgid=286698601/17/2013 11:36:38 AMMissionIRExcitement at VistaGen Therapeutics (VSTA) Continues to Build A lot of great things have been happening with VistaGen Therapeutics recently. VistaGen is a California-based biotechnology company actively applying its proprietary human pluripotent stem cell technology to launch a new era of drug rescue, predictive hea...http://www.siliconinvestor.com/readmsg.aspx?msgid=2861589812/19/2012 8:13:31 PMMissionIRThe Long Term Strategy for VistaGen Therapeutics (VSTA) VistaGen Therapeutics is focused primarily on the use of its proprietary pluripotent stem cell technology to discover, rescue, and develop novel drug candidates for a wide range of diseases. The idea is to generate new chemical variants of once-promising small ...http://www.siliconinvestor.com/readmsg.aspx?msgid=2859500712/10/2012 11:52:58 AMMissionIRVistaGen Therapeutics, Inc. (VSTA) Joins Centre for Commercialization of Regenerative Medicine (CCRM) Consortium VistaGen Therapeutics, a biotechnology company applying stem cell technology for drug rescue, predictive toxicology and drug metabolism screening, today announced its membership in the Toronto-based Centr...http://www.siliconinvestor.com/readmsg.aspx?msgid=2858232212/3/2012 5:31:43 PMMissionIRVistaGen Therapeutics (VSTA) Focused on Preventing Some Very Costly Surprises Recently, when Bristol-Myers Squibb was forced to suspend testing of its pill for hepatitis C because one of the patients suffered heart failure, it was a major blow to the pharmaceutical giant. Bristol had spent more than a billion dollar...http://www.siliconinvestor.com/readmsg.aspx?msgid=2856157411/21/2012 10:16:49 AMMissionIRVistaGen Therapeutics, Inc. (VSTA) Announces Enhancement of Predictive Liver Toxicology and Drug Metabolism Bioassay System VistaGen Therapeutics, a biotechnology company applying stem cell technology for drug rescue, predictive toxicology, and drug metabolism screening, today announced a significant advance in its ...http://www.siliconinvestor.com/readmsg.aspx?msgid=2854442511/13/2012 11:09:40 AMMissionIRVistaGen Therapeutics, Inc. (VSTA) Taps the Turnaround The idea of a turnaround is often associated with dysfunctional companies being purchased by outsiders or otherwise given new management, and then being transformed with a change in product, structure, or philosophy, providing a fresh and profitable direction fo...http://www.siliconinvestor.com/readmsg.aspx?msgid=2854288611/12/2012 4:16:30 PMMissionIRVistaGen Therapeutics, Inc. (VSTA) Presents Heart Tissue Engineering Progress at American Heart Association 2012 Scientific Sessions VistaGen Therapeutics, a biotechnology company applying stem cell technology for drug rescue, predictive toxicology and drug metabolism screening, today announced that results of their...http://www.siliconinvestor.com/readmsg.aspx?msgid=2852975211/7/2012 11:51:21 AMMissionIRVistaGen Therapeutics, Inc. (VSTA) Human Clinical Trials in a Test Tube Platform a Drug Discovery and Rescue Gold Mine VistaGen Therapeutics, the rapidly evolving biotech firm that is advancing a stem cell-based technology platform focused on controlling pluripotent stem cell differentiation for application in drug ...http://www.siliconinvestor.com/readmsg.aspx?msgid=2849060010/22/2012 2:15:20 PMMissionIRVistaGen Therapeutics, Inc. (VSTA) Secures $3.25 Million Financing and Completes $3.0 Million Debt Restructuring VistaGen Therapeutics, a biotechnology company applying human pluripotent stem cell technology for drug rescue and novel pharmaceutical assays, just announced the completion of the previously announced $3...http://www.siliconinvestor.com/readmsg.aspx?msgid=2847611610/16/2012 9:46:40 AMMissionIRVistaGen Therapeutics, Inc. (VSTA) and Neuropathic Pain VistaGen Therapeutics is best known for having developed a versatile stem cell technology platform which can be used to produce superior testing options for new drug candidates, with the potential of saving the drug industry millions or even billions of dollars...http://www.siliconinvestor.com/readmsg.aspx?msgid=2846145710/9/2012 9:53:28 AMMissionIRVistaGen Therapeutics, Inc. (VSTA) is “One to Watch” VistaGen Therapeutics is a biotechnology company applying stem cell technology for drug rescue and cell therapy. Drug rescue combines human stem cell technology with modern medicinal chemistry to generate new chemical variants (“drug rescue variants”) of once-prom...http://www.siliconinvestor.com/readmsg.aspx?msgid=2844882310/3/2012 10:12:14 AMMissionIRVistaGen Therapeutics (VSTA) Stem Cell Initiatives Led by Bio-Oriented Management Team South San Francisco, California-based VistaGen Therapeutics has developed a versatile stem cell technology platform based on the controlled differentiation of human pluripotent stem cells into multiple types of mature, non-transfo...http://www.siliconinvestor.com/readmsg.aspx?msgid=284342609/26/2012 9:08:32 AMMissionIRVistaGen Therapeutics (VSTA) Helps Get the Drug to Where It’s Needed The pharmaceutical industry has invested billions of dollars developing drugs that can do truly amazing things once they are successfully applied. However, one of the historic challenges faced by the healthcare industry has been to figure out bette...http://www.siliconinvestor.com/readmsg.aspx?msgid=284174339/18/2012 5:43:17 PMMissionIRVistaGen Therapeutics, Inc. (VSTA) Secures Additional Financing from Largest Institutional Investor and Completes Long-term Debt Restructuring VistaGen Therapeutics, a biotechnology company applying stem cell technology for drug rescue and novel pharmaceutical assays for predictive heart and liver toxicology and dru...http://www.siliconinvestor.com/readmsg.aspx?msgid=283882039/6/2012 9:57:26 AMMissionIRVistaGen Therapeutics (VSTA) Addresses Shortage of New Drugs A report in PharmaTimes online points to a report from Fitch Ratings, one of the Big Three credit rating agencies, warning that the U.S. Food and Drug Administration (FDA) will approve fewer novel drugs in 2012 than it did in 2011. According to the FDA’s C...http://www.siliconinvestor.com/readmsg.aspx?msgid=283240918/9/2012 11:32:04 AMMissionIRVistaGen Therapeutics (VSTA) Goes Beyond Drug Testing VistaGen is known best for its proprietary stem cell technology used in their novel bioassay systems to provide superior toxicity testing of new drug candidates. The company’s Human Clinical Trials in a Test TubeTM platform is designed to provide accurate and ear...http://www.siliconinvestor.com/readmsg.aspx?msgid=283099608/2/2012 12:21:16 PMMissionIRVistaGen Therapeutics (VSTA) to Revolutionize Drug Development and Save Big Pharma Hundreds of Millions by Putting Humans First VistaGen Therapeutics is a biotechnology company focused primarily on the use of its proprietary pluripotent stem cell technology to discover, rescue, and develop novel drug candidates for ...http://www.siliconinvestor.com/readmsg.aspx?msgid=282777167/19/2012 12:30:10 PMMissionIRVistaGen Therapeutics (VSTA) Promotes Efficient Drug Development The understanding and mastery of human stem cells has grown into a major industry. It is becoming increasingly clear that stem cells play an ongoing and vital role in the human body, and knowing how to work with them could open up a world of disease tr...http://www.siliconinvestor.com/readmsg.aspx?msgid=282344646/28/2012 4:23:04 PMMissionIRVistaGen Therapeutics’ (VSTA) Stem Cell Technology Has Multiple Applications VistaGen has developed a unique and versatile stem cell technology platform with a number of applications. The platform itself is based upon the controlled differentiation of human pluripotent stem cells into mature non-transformed cells. T...http://www.siliconinvestor.com/readmsg.aspx?msgid=282217726/22/2012 10:21:54 AMMissionIRThe Technology Behind VistaGen Therapeutics (VSTA) VistaGen is best known for its development of technologies that could revolutionize the testing of new drug candidates, potentially saving pharmaceutical companies billions of dollars by helping them select the most promising drug development opportunities and creat...http://www.siliconinvestor.com/readmsg.aspx?msgid=282071486/14/2012 3:33:35 PMMissionIRVistaGen Therapeutics, Inc. (VSTA) Offers Solution to a Critical Pharmaceutical Industry Problem VistaGen, developer of stem cell technologies for improved drug testing, has emphasized that using stem cell-based bioassay systems could save pharmaceutical developers tremendous amounts of money through the use of accu...http://www.siliconinvestor.com/readmsg.aspx?msgid=281889386/5/2012 12:33:05 PMMissionIRVistaGen Therapeutics (VSTA) CEO Shawn Singh Provides Operational Update and Forward Guidance VistaGen Therapeutics, the ingenious biotech firm advancing potentially game-changing technology via a spectrum approach that combines the company’s Human Clinical Trials in a Test Tube™ platform with aggressive, novel chem...http://www.siliconinvestor.com/readmsg.aspx?msgid=281675165/24/2012 4:32:41 PMMissionIRVistaGen Therapeutics (VSTA) Strategic Collaborators VistaGen, a California-based developer of advanced stem cell technologies to create superior drug testing options for pharmaceutical companies, considers strategic collaborators as a cornerstone of its corporate development strategy. To this end, VistaGen has selec...http://www.siliconinvestor.com/readmsg.aspx?msgid=281538435/18/2012 9:33:23 AMMissionIRVistaGen Therapeutics (VSTA) CEO Shawn Singh Issues Shareholder Update Letter VistaGen Therapeutics, a biotechnology company applying stem cell technology for drug rescue, today issued the following letter to its stockholders and the investment community from its CEO, Shawn Singh. To our valued Stockholders: Since...http://www.siliconinvestor.com/readmsg.aspx?msgid=281428905/14/2012 9:19:47 AMMissionIR VistaGen Therapeutics (VSTA) Presents Unprecedented Solution to Staggering Drug Development Costs The business model used by VistaGen Therapeutics targets the billions of dollars spent by the pharmaceutical industry to discover, optimize, and validate the potential efficacy of new drug candidates, taking a drug candi...http://www.siliconinvestor.com/readmsg.aspx?msgid=281256025/4/2012 4:48:59 PMMissionIRVistaGen Therapeutics (VSTA) Develops Superior Drug Testing Technology Human pluripotent stem cells are the foundation for VistaGen’s development of advanced stem cell technologies to create superior drug testing opportunities for pharmaceutical companies. Pluripotent stem cells are able to self-renew as well as dif...http://www.siliconinvestor.com/readmsg.aspx?msgid=281148374/30/2012 9:35:50 AMMissionIRVistaGen Therapeutics (VSTA) Awarded U.S. Stem Cell Technology Patent Covering Methods Used to Test Drug Candidates for Liver Toxicity VistaGen Therapeutics, Inc., a biotechnology company applying stem cell technology for drug rescue, just announced it has secured a new United States patent covering the company’s p...http://www.siliconinvestor.com/readmsg.aspx?msgid=281080884/26/2012 12:33:15 PMMissionIRVistaGen Therapeutics (VSTA) and Multiple Valuations Traditionally, the fundamental value of a company was based upon the potential of its products in the marketplace and the future earnings those products could support. In short, the value of a company centered around what people thought the company would do. Ultim...http://www.siliconinvestor.com/readmsg.aspx?msgid=280996794/23/2012 11:49:31 AMMissionIRVistaGen Therapeutics, Inc. (VSTA) to Speed Development of Drug Screening and Cell Therapy for Immune System Disorders through License Agreement Today before the opening bell, VistaGen Therapeutics, a biotechnology company applying stem cell technology for drug rescue, announced it has licensed breakthrough stem cel...http://www.siliconinvestor.com/readmsg.aspx?msgid=280843524/16/2012 10:19:11 AM